Contact this trialFirst, we need to learn more about you.
Procedure
GLP-1 Analogue Therapy for Cardiometabolic Risk in Type 1 Diabetes
Recruiting1 awardPhase 1
New Haven, Connecticut
This trial aims to better understand how T1D with overweight/obesity can reduce cardiometabolic risk by studying how their bodies respond to GLP-1 analogue therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.